Culturally tailored program aims to help black and latinx drug users get the support they need
NCT ID NCT05776316
First seen Mar 27, 2026 · Last updated Jun 12, 2026 · Updated 10 times
Summary
This study tests whether a culturally tailored harm reduction program helps Black and Latinx people who use drugs engage more with support services and reduce their drug use. Researchers will compare the new program to standard harm reduction services. The study involves 200 adults who have misused opioids or stimulants in the past month.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG USE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health
NOT_YET_RECRUITINGNew York, New York, 10016, United States
Contact Email: •••••@•••••
-
Nathan Kline Institute
RECRUITINGOrangeburg, New York, 10962, United States
Contact
-
Yale University
RECRUITINGNew Haven, Connecticut, 06520, United States
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.